A blog about what is new (and old) in the world of active implantable medical devices 

Facebook Twitter Gplus Flickr LinkedIn YouTube RSS
magnify
Home Therapies Archive for category "Neural Stimulation" (Page 4)
formats

Functional Neuromodulation Ltd. Starts Study using DBS of the Fornix (DBS-f) for Mild Alzheimer’s

Toronto-based Functional Neuromodulation announced that it implanted the first U.S. Alzheimer’s patient in the “ADvance Study” with a deep brain stimulation (DBS) system meant to improve cognitive performance. ADvance will evaluate the safety and potential clinical benefit of DBS of the fornix (DBS-f), a major inflow and output pathway in the brain’s memory circuit, for

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on Functional Neuromodulation Ltd. Starts Study using DBS of the Fornix (DBS-f) for Mild Alzheimer’s  comments 
formats

Boston Scientific’s Precision Spectra™ SCS with 32 Contacts and 32 Dedicated Power Sources Receives CE Mark

Boston Scientific Received European Regulatory Approval For New Precision Spectra™ Spinal Cord Stimulator System.  It is the first and so-far only SCS system with 32 contacts and 32 dedicated power sources designed to provide pain relief to a broad spectrum of chronic pain patients.

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on Boston Scientific’s Precision Spectra™ SCS with 32 Contacts and 32 Dedicated Power Sources Receives CE Mark  comments 
formats

Boston Scientific Receives CE Mark of Vercise™ Deep Brain Stimulation System

Boston Scientific Corporation received CE Mark approval for use of its Vercise™ Deep Brain Stimulation (DBS) System for the treatment of Parkinson’s disease. The Vercise DBS System is the first and only commercially available DBS system to incorporate multiple independent current control, which is designed to selectively stimulate targeted areas in the brain. This system is

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on Boston Scientific Receives CE Mark of Vercise™ Deep Brain Stimulation System  comments 
formats

First Human Use of 24-Electrode Retinal Implant by Bionic Vision Australia

Bionic Vision Australia researchers announced on August 30, 2012 that they successfully performed the first implantation of an early prototype bionic eye with 24 electrodes. According to the press release:

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on First Human Use of 24-Electrode Retinal Implant by Bionic Vision Australia  comments 
formats

St. Jude Medical Receives CE Mark Approval of Eon Mini to Treat Chronic Migraine

St. Jude Medical announced it has received European CE Mark approval of its Eon™ family of neurostimulators for treating patients with intractable chronic migraine. According to the press release: “Intractable chronic migraine is one of the most difficult-to-treat headache disorders,” said Professor Gennaro Bussone, M.D., head of the Neurological Department at Istituto Besta in Milan

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on St. Jude Medical Receives CE Mark Approval of Eon Mini to Treat Chronic Migraine  comments 
formats

Nevro Receives FDA Approval to Initiate Trial of its High-Frequency Spinal Cord Stimulation Therapy

Nevro Corp announced that FDA has granted approval for initiation of its SENZA-RCT study, a U.S. prospective, randomized, controlled pivotal clinical trial evaluating the safety and efficacy of Nevro’s high-frequency spinal cord stimulation system for the treatment of chronic pain.

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
1 Comment  comments 
formats

EnteroMedics Reports $123k Revenue from Sales of its Maestro RC IPG for Treatment of Obesity

Today EnteroMedics recorded revenue for the first time since it was incorporated nearly eight years ago. The company reported revenue of about $123,000 in the first quarter of the year from the sale of its Maestro RC implantable vagus nerve stimulation system for treating obesity. Revenue was generated through sales by its distribution partner in Australia.

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on EnteroMedics Reports $123k Revenue from Sales of its Maestro RC IPG for Treatment of Obesity  comments 
formats

Monash University in Australia Starts Test of Direct-to-Brain Visual Prosthesis Chips

Engineers from the Monash Vision Group (MVG) have begun trialling the ASICs for a direct-to-brain visual prosthesis that is expected to enter human clinical trials in 2014. The prosthesis will consist of a tiny camera mounted into a pair of glasses, which acts as the retina; a pocket processor, which takes the electronic information from

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on Monash University in Australia Starts Test of Direct-to-Brain Visual Prosthesis Chips  comments 
formats

John Hopkins Researcher Develops New Early-Warning Seizures Detector with Low False-Positive Rate

Johns Hopkins’ Sridevi V. Sarma, an assistant professor of biomedical engineering, has devised new seizure detection software that, in early testing, significantly cuts the number of unneeded brain-stimulation therapy that an epilepsy patient would receive. According to Sarma, “These devices use algorithms—a series of mathematical steps—to figure out when to administer the treatment,” Sarma said. “They’re

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on John Hopkins Researcher Develops New Early-Warning Seizures Detector with Low False-Positive Rate  comments 
formats

Neuromed’s TIME Battery- and RF-Powered Totally Implantable Multichannel Spinal Cord Stimulator (ca. 1988)

Neuromed was formed in 1980 with an initial capitalization of $150,000 by Bill Borkan through money obtained when Borkan`s parents took out a second mortgage on their home. Borkan’s desire to help his sister, Jennie, a cerebral palsy patient, got him started in neurostimulation technology. In the next few years, Neuromed developed and marketed a

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on Neuromed’s TIME Battery- and RF-Powered Totally Implantable Multichannel Spinal Cord Stimulator (ca. 1988)  comments 
formats

St. Jude’s (ANS) Rechargeable Spinal Cord Stimulators Eon and Eon Mini

In 2005, St. Jude Medical purchased Advanced Neuromodulation Systems (ANS) in Plano, Texas.  ANS had developed a number of spinal cord stimulation IPGs that were either externally powered via inductive link, internally powered by a primary cell, or internally powered by a transcutaneously rechargeable lithium-ion cell. Today, the most popular St. Jude spinal cord stimulators are the rechargeable

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
1 Comment  comments 
formats

St. Jude’s DBS Study Confirms Benefit of Constant Current System for Parkinson’s Disease

Image Credit: St. Jude Medical Today St. Jude announced that its first controlled study of Deep Brain Stimulation (DBS) confirms benefit of constant current system for patients with Parkinson’s Disease. Results were published online today by The Lancet Neurology journal. The aim of the study was to evaluate the Libra(TM) and LibraXP(TM) DBS constant current systems

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on St. Jude’s DBS Study Confirms Benefit of Constant Current System for Parkinson’s Disease  comments 
formats

Biotectix

Image Credit: Biotectix Biotectix of Ann Arbor, MI recently contacted me to let me know of new conductive polymer materials that they are developing to enhance the performance of next-gen implantable stimulation and sensing devices. Indeed, their materials sound very promising.  According to Biotectix, their electrode coatings and device components are made from proprietary conducting polymers that provide

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on Biotectix  comments 
formats

NDI Medical’s Miniature MicroPulse Neurostimulator

Image Credit: SPR Therapeutics NDI Medical was founded in 2002 by Geoffrey B. Thrope to develop and commercialize neurodevice products.  NDI Medical developed the MicroPulse neurostimulator, a thumb-sized, rechargeable pulse generator, that has been used for the treatment of incontinence and pain, as well as an implantable device for the restoration of function of paralyzed limbs. According to a 2006

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on NDI Medical’s Miniature MicroPulse Neurostimulator  comments 
formats

Leptos Biomedical’s Splanchnic Nerve Stimulation For Treatment Of Obesity (2002-2010)

Leptos Biomedical was founded in Fridley, MN in 2002 by Dr. John D. Dobak.   Leptos intended to develop an implantable device to stimulate the greater splanchnic nerve, that was hoped would  result in reduced food intake and increased energy expenditure. In February 2010 Leptos announced its closure.  Reasons were not provided, but it has been suggested that the decision

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on Leptos Biomedical’s Splanchnic Nerve Stimulation For Treatment Of Obesity (2002-2010)  comments